Dr. Stephen DePasquale, MD
Claim this profileChattanooga's Program in Women's Oncology
Studies Ovarian Cancer
Studies Ovarian Tumors
8 reported clinical trials
13 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
NTRK1 positive
2Ovarian Tumors
Stage IV
Stage III
BRCA1
Affiliated Hospitals
Clinical Trials Stephen DePasquale, MD is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 313 criteria
Robotic vs Open Hysterectomy
for Cervical Cancer
This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.
Recruiting1 award N/A8 criteria
More about Stephen DePasquale, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Stephen DePasquale, MD has experience with
- Carboplatin
- GEN-1
- VMD-928
- Olvimulogene Nanivacirepvec
- Gemcitabine
- Bevacizumab
Breakdown of trials Stephen DePasquale, MD has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Peritoneal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen DePasquale, MD specialize in?
Stephen DePasquale, MD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Stephen DePasquale, MD currently recruiting for clinical trials?
Yes, Stephen DePasquale, MD is currently recruiting for 4 clinical trials in Chattanooga Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Stephen DePasquale, MD has studied deeply?
Yes, Stephen DePasquale, MD has studied treatments such as Carboplatin, GEN-1, VMD-928.
What is the best way to schedule an appointment with Stephen DePasquale, MD?
Apply for one of the trials that Stephen DePasquale, MD is conducting.
What is the office address of Stephen DePasquale, MD?
The office of Stephen DePasquale, MD is located at: Chattanooga's Program in Women's Oncology, Chattanooga, Tennessee 37403 United States. This is the address for their practice at the Chattanooga's Program in Women's Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.